According to a recent survey from the Kaiser Family Foundation, almost every state Medicaid plan is concerned about the rising cost of specialty drugs — specifically Sovaldi. Sovaldi is a hepatitis c drug from Gilead Sciences which costs $1,000 a pill, or $84,000 for a 12-week treatment—prices which the plans have balked at.